A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas.
Zhou Y, Li M, Zhang B, Yang C, Wang Y, Zheng S, Tang L, Zhou C, Qian G, Huang Y, Yu W, Li H, Wang Y, He A, Shen Z, Zhang J, Li X, Yang Q, Hu H, Yao Y.
Zhou Y, et al. Among authors: qian g.
BMC Med. 2023 Nov 29;21(1):470. doi: 10.1186/s12916-023-03132-x.
BMC Med. 2023.
PMID: 38031088
Free PMC article.
Clinical Trial.